P&L Analysis Metalurgica Galaica Acerinos Arcelormittal

Revenue 6,431 30,427 42,281

As % Revenue;
Gross Margin 63.3% 51.1% 75.9%
EBITDA 47.1% 48.7% 17.5%
EBIT 39.4% 7.5% 13.8%
EBT 38.4% 6.8% 9.7%
Net Income 36.9% 6.2% 6.4%
Efective Tax Rate 4.0% 8.8% 33.5%

Gross Margin 4,073 15,551 32,107

EBITDA 3,032 14,816 7,402
EBIT 2,534 2,272 5,837
EBT 2,470 2,063 4,089
Net Income 2,370 1,882 2,719

Commentary

All this companies have good results, this means they have profits.
The best is Arcelomittal because the net income is the highest. The
second is Metalurgica Galaica, wich have a small revenue but has less
cost than the others so its net income is not so bad. Acerinos has the
second higher goss margin and revenues but the net income is the
third; that is caused by higher costs. The last one is Compañia
Española de Laminacion.

ROE

ROIC
Compañía Española de Laminacion
1,456

52.3%
44.1%
18.5%
18.0%
17.0%
5.7%

762
642
270
262
247
 Commodities Inc
Profit and Loss Statement
2017 2018 2019

Revenue 250.0 275.0 302.5

Cost of Revenue 175.0 192.5 211.8

Gross Margin 75.0 82.5 90.8

%Revenue 30.0% 30.0% 30.0%

Total Expenses 60.0 61.8 63.7

% Revenue 24.0% 22.5% 21.0%

Operating Income (EBIT) 15.0 20.7 27.1

% Revenue 6.0% 7.5% 9.0%

Financial Income/(Exp) (2.5) (2.3) (2.0)

Income before Taxes 12.5 18.5 25.1

###Taxes (3.1) (4.6) (6.3)

Net Income 9.38 13.84 18.82 ASSETS 2017

Cash & Equivalents 3.5
Memo: Accounts Receivable 41.7
Depreciation 10 10 10 Inventrories 16.0
EBITDA 25.00 30.70 37.10 Current Assets 61.3

PP&E 60.0
Loan 50 45.0 40.0 35.0 (Additions - Depreciac.) 0.0
Interests (2.5) (2.3) (2.0) Non Current Assets 60.0
Total Assets 121.3

2018
32.1
5
37.1
35

54.4
13.8
68.2
140.3
K-Genomics. Plan 2017

2018 2017 2016 %

Antiflu 7,920 7,200 6,600
Antialergic 1 4,800 4,800 4,400
Antialergic 2 1,000
Total Revenue 13,720 12,000 11,000 9.1%
Antiflu 5,544 5,040 4,500
Antialergic 1 3,360 3,360 3,000
Antialergic 2 700
Total Cost of Product 9,604 8,400 7,500 12.0%
Other Costs 1,201 1,050 930 12.9%
Gross Margin 2,916 2,550 2,570 -0.8%
% Revenue 21.3% 21.3% 23.4%
R&D Expense 200 200 200 0.0%
Marketing 230 230 220 4.5%
Selling 850 850 790 7.6%
G&A Expense 512 640 615 4.1%
Total Expenses 1,792 1,920 1,825 5.2%
% Revenue 13.1% 16.0% 16.6%
Operating Income (EBIT) 1,124 630 745 -15.4%
% Revenue 8.2% 5.3% 6.8%

Financial Income /(Exp) -160 -160 -140

Other Income / (Exp) 0 90 -25
Income Before Taxes (EBT) 964 560 580 -3.4%
Taxes -241 -140 -174 -19.5%
Net Income 723 420 406 3.4%

En el escenario neutral no precisa aplicar la reducción del 20% de gastos generales. Únicamente en el desfavorable
 ACTIVO 2018 2017 2016 % LIABILITIES 2018

Cash and Equivalents 1,332 90 140 Accounts Payable 1,320

Accounts Receivable 2,112 2,448 2,100 Shot-Term Debt 300
Inventory 739 1,100 910 Dividends Payable 300
Total Current Assets 4,183 3,638 3,150 Current Liabilities 1,920
Long Term Loans 1,000
PP&E 1,205 1,240 1,210 Intercompany Loans 1,032
Intangible Assets 1,083 1,250 1,400 Capital 500
Total Non-Current Assets 2,288 2,490 2,610 Retained Earnings 2,019
Total Equity 2,519
TOTAL ASSETS 6,471 6,128 5,760 TOTAL LIABILITIES &EQ 6,471

Beginning PP&E 1,240

Additions 150
Depreciation -185
Ending PP&E 1,205

Beginning Intangible 1,250 Cash Flow

Amortization -167 Net Income 723
Ending Intangible Assets 1,083 Depreciation & Amort 352
Change in Working Cap 817
Cash fm Operations 1,891

Investments/Disinvestment -150
generales. Únicamente en el desfavorable Cash from Investment -150

Loans received/paid -500

Dividends paayable 0
Cash frm Financing -500

TOTAL CASH FLOW 1,241

Cash at the beginning Year 90
Cash at the end of the Year 1,332
Cash difference 1,242
2017 2016 %

1,200 1,180
300 320

1,500 1,500
1,000 1,000
1,532 1,360
500 500
1,596 1,400
2,096 1,900
6,128 5,760
Short Term Cash Flow Exercise
Q1 Q2 Q3 Q4
Beginning Receivables 250 167 200 217
Sales 500 600 650 800 550
Cash Collections 583 567 633 750
Ending Receivables 167 200 217 267

Q1 Q2 Q3 Q4
Payment of accounts 275 313 363 338
Wages, taxes and other expenses 150 180 195 240
Capital expenditures 0 200 0 0
Interest and dividend payments 50 50 50 50
Total cash disbursements 475 743 608 628

Q1 Q2 Q3 Q4
Total cash collections 583 567 633 750
Total cash disbursements 475 743 608 628
Net cash inflow 108 -176 26 123
Beginning Cash Balance 80 188 13 38
Net cash inflow 108 -176 26 122.5
Ending cash balance 188 12.5 38 161
Minimum cash balance -50 -50 -50 -50
Cumulative surplus (deficit) 138 -38 -12 111
 Mad_Consulting
Total Year Outlook
(Figures in Euro 000s)

Q3 YTD Q3 YTD Q3 YTD % % Q4 Q4 Q4 % % Year Year Year % %

Actual Budget Prior Act/Bgt Act/Prior Outlook Budget Prior Act/Bgt Act/Prior Actual Budget Prior Act/Bgt Act/Prior
Net Consulting Revenue 54,749 56,063 53,025 -2.3% 3.3% 16,873 18,085 17,105 -6.7% -1.4% 71,622 74,148 70,130 -3.4% 2.1%
Other Revenue 17,431 16,513 15,470 5.6% 12.7% 4,160 5,160 4,990 -19.4% -16.6% 21,591 21,673 20,460 -0.4% 5.5%
TOTAL NET SALES 72,180 72,576 68,495 -0.5% 5.4% 21,033 23,245 22,095 -9.5% -4.8% 93,213 95,821 90,590 -2.7% 2.9%

Production Personnel Costs 24,513 28,504 27,188 -14.0% -9.8% 8,171 8,908 8,770 -8.3% -6.8% 32,684 37,412 35,958 -12.6% -9.1%
External Consultant Costs 2,789 1,896 1,936 47.1% 44.1% 1,093 593 625 84.4% 74.9% 3,882 2,489 2,561 56.0% 51.6%
Subcontractors 15,411 12,016 11,459 28.3% 34.5% 3,696 3,755 3,696 -1.6% 0.0% 19,107 15,771 15,155 21.2% 26.1%
Office Costs 3,366 2,408 2,260 39.8% 48.9% 1,122 753 729 49.1% 53.9% 4,488 3,161 2,989 42.0% 50.1%
Depreciation 1,139 1,103 1,024 3.3% 11.2% 380 345 330 10.1% 14.9% 1,519 1,448 1,354 4.9% 12.1%
Other 4,617 4,520 4,325 2.1% 6.8% 1,539 1,413 1,395 9.0% 10.3% 6,156 5,933 5,720 3.8% 7.6%
NET PRODUCTION COSTS 51,835 50,447 48,192 2.8% 7.6% 16,001 15,765 15,546 1.5% 2.9% 67,836 66,212 63,738 2.5% 6.4%

GROSS MARGIN 20,345 22,129 20,303 -8.1% 0.2% 5,032 7,480 6,549 -32.7% -23.2% 25,377 29,609 26,852 -14.3% -5.5%
% of Net Sales 28.2% 30.5% 29.6% 23.9% 32.2% 29.6% 27.2% 30.9% 29.6%

Sales Personnel Costs 3,062 3,421 3,190 -10.5% -4.0% 1,021 1,069 1,029 -4.5% -0.8% 4,083 4,490 4,219 -9.1% -3.2%
PR and Advertising 596 416 382 43.3% 56.0% 199 130 123 52.8% 61.2% 795 546 505 45.5% 57.3%
Depreciation 295 220 210 34.1% 40.5% 98 69 68 43.0% 45.2% 393 289 278 36.2% 41.6%
Other 303 402 287 -24.6% 5.6% 101 126 93 -19.6% 9.1% 404 528 380 -23.4% 6.4%
Net Sales Costs 4,256 4,459 4,069 -4.6% 4.6% 1,419 1,393 1,313 1.8% 8.1% 5,675 5,852 5,382 -3.0% 5.4%
% of Revenue 5.9% 6.1% 5.9% 6.7% 6.0% 5.9% 6.1% 6.1% 5.9%

Admin Personnel Costs 2,080 2,732 2,640 -24% -21.2% 624 854 852 -27% -26.7% 2,704 3,586 3,492 -25% -22.6%
Office Costs 1,403 1,725 1,675 -19% -16.2% 421 539 540 -22% -22.1% 1,824 2,264 2,215 -19% -17.7%
Depreciation 438 454 431 -4% 1.6% 131 142 139 -7% -5.5% 569 596 570 -4% -0.1%
Other 183 112 99 63% 84.8% 55 35 32 57% 71.9% 238 147 131 62% 81.7%
Net Admin Costs 4,104 5,023 4,845 -18% -15.3% 1,231 1,570 1,563 -22% -21.2% 5,335 6,593 6,408 -19% -16.7%
% of Net Sales 5.7% 6.9% 7.1% 5.9% 6.8% 7.1% 5.7% 6.9% 7.1%

Operating Income 11,985 12,647 11,389 -5% 5.2% 2,382 4,517 3,674 -47% -35.2% 14,367 17,164 15,063 -16% -4.6%
% of Net Sales 16.6% 17.4% 16.6% 11.3% 19.4% 16.6% 15.4% 17.9% 16.6%
Other Income 32 0 0 0 0 0 0 0 0 0 0 0
Income Before Taxes 12,017 12,647 11,389 -5% 5.5% 2,382 4,517 3,674 -47% -35.2% 14,367 17,164 15,063 -16% -4.6%
Taxes 3,605 3,794 3,417 715 1,355 1,102 4,310 5,149 4,519
Net Income 8,412 8,853 7,972 -5% 5.5% 1,668 3,162 2,572 -47% -35.2% 10,057 12,015 10,544 -16% -4.6%
% of Net Sales 11.7% 12.2% 11.6% 7.9% 13.6% 11.6% 10.8% 12.5% 11.6%

Total Production Headcount 172 178 175 172 178 175 0 0 175
Sales, Admin and Other 28 36 33 26 36 33 0 36 33
Total Headcount 200 214 208 198 214 208 0 36 208

Ratios on an annualized basis

Productivity Total 361 339 329 106 109 106 2,662 436

Productivity Billable 420 408 391 122 131 126 #DIV/0! #DIV/0! 518
Cost per Billable Head 143 160 155 48 50 50 #DIV/0! #DIV/0! 205
# KPI

1 Average room rates (ARR)

2 Average daily rate of the room (ADR)

3 Revenue per Available Room (Revpar)

4 Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA)

5 Gross Operating ProfiT (GOP)

 Follow-Up
Formula
(D/M/Q/Y)

Total Room Revenue / Total Rooms Occupied monthly or weekly

Room revenue(per day) / room sold (per day) daily

Rooms Revenue / Rooms Available annually

Revenue - Expenses* annually

Gross Operating Revenue - Gross Operating Expenses annually

It measures the average rate per available room for a longer period of time (weekly, monthly).They are necessary to measure t

It measures the average rate per available room of one day.They are necessary to measure the financial performance of the ho

It is one of the most important financial calculations for any hotel to know how much revenue they have made within a certain

It is used to determine how profitable a company or business is with regard to its operations (the profit on the products it prod

Hotels profits after subtracting all of their operating expenses. It illustrates the level of operational profitability of a hotel.
 End Users

Company

Company

Company

Company

Company